Yoshiyuki Endo
Fukushima Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshiyuki Endo.
Oncogene | 2003
Toshihiko Fukushima; Shinichi Suzuki; Miyuki Mashiko; Tohru Ohtake; Yoshiyuki Endo; Yuji Takebayashi; Koji Sekikawa; Koichi Hagiwara; Seiichi Takenoshita
BRAF is a serine/threonine kinase that receives a mitogenic signal from RAS and transmits it to the MAP kinase pathway. Recent studies have reported that mutations of the BRAF gene were detected with varying frequencies in several cancers, notably more than 60% in melanoma. We analysed mutations of BRAF and RAS genes in 100 cases of thyroid carcinoma to investigate genetic aberrations in the RAS/RAF/MEK/MAP kinase pathway. BRAF mutations were detected exclusively in papillary carcinomas (40 in 76 cases: 53%), and were exclusively V599E, a mutation frequently observed in other carcinomas. NRAS mutation was observed in six cases (6%), all in histological types other than papillary carcinoma, and was exclusively Q61R. No mutations were found in KRAS or HRAS. Our results suggest that BRAF mutations may play a critical role in the carcinogenesis of papillary carcinoma of the thyroid.
Surgery Today | 2006
Atsuo Tsuchiya; Yoshiyuki Endo; Takashi Yazawa; Atsuko Saito; Norio Inoue
Adenoendocrine cell carcinoma of the gallbladder is an uncommon form of cancer. We treated a 36-year-old woman who came to us with a chief complaint of abdominal pain. The abnormality was diagnosed to be a tumor-like mass in the gallbladder, and adenomyomatosis of the gallbladder was strongly suspected. A laparoscopic cholecystectomy was successfully performed, and the histopathological finding was adenoendocrine cell carcinoma of the gallbladder. The tumor cells of the small round cell carcinoma partly stained positively for synaptophysin, neuron-specific enolase, and CD 56, while adenocarcinoma cells showed positive reactions to keratin, which was thus suggestive of adenoendocrine cell carcinoma. The patient is alive and doing well at 12 months after the treatment.
Breast Cancer | 1999
Atsuo Tsuchiya; Masahiko Kanno; Takanori Kawaguchi; Yoshiyuki Endo; Guo-Jun Zhang; Tohru Ohtake; Izo Kimijima
BackgroundAbnormal glycosylation patterns have been recognized as a feature of carcinoma-associated mucins. The expression of the Tn antigen in breast cancer tissue was investigated to assess its prognostic relevance.MethodsFormalin-fixed, paraffin-embedded materials from 219 patients with breast cancer were used. Immunohistochemical staining of the Tn antigen was retrospectively investigated and a lesion staining 10% or more was considered positive.ResultsTn antigen expression was present in 99 (45%) of 219 lesions. There were no correlations between Tn antigen expression and mean patient age, nodal status, estrogen receptor status, or menopausal status, but there was a slightly significant association between Tn and tumor size. Patients negative for the Tn antigen had a significantly better survival rate than those who were positive. Multivariate analysis also indicated that Tn expression correlated significantly with overall survival in addition to nodal status and tumor size.ConclusionsTn expression was a significant prognostic factor in breast cancer, but the significance was lost on multivariate analysis. The biological implication of Tn expression in breast cancer needs further investigation.
Surgery Today | 2000
Atsuo Tsuchiya; Hiroshi Furukawa; Yoshiyuki Endo; Izumi Nakamura; Shinichi Suzuki; Seiichi Takenoshita; Hajime Odajima; Sayuri Suzuki
Abstract We report herein the case of a 61-year-old man who was referred to our hospital for treatment of a rapidly growing tumor in the right anterior cervical region. A 13 × 14 × 15 cm mass was palpated on physical examination. Computed tomography (CT) findings indicated a thyroid tumor, but cytology results suggested rhabdomyosarcoma. A tumor, measuring 9.3 × 7.2 × 5.2 cm and weighing 220 g, was resected and histopathological examination confirmed a diagnosis of rhabdomyosarcoma. Cervical rhabdomyosarcoma is rarely found in adults.
International Journal of Molecular Medicine | 1999
Izumi Nakamura; I Kimijima; G J Zhang; H. Onogi; Yoshiyuki Endo; Sayuri Suzuki; A Tuchiya; Seiichi Takenoshita; Takashi Kusakabe; Toshimitsu Suzuki
Anticancer Research | 2004
Arifumi Hasegawa; Toshihiko Fukushima; Miyuki Mashiko; Keiichi Nakano; Satoshi Suzuki; Yoshiyuki Endo; Shinji Ohki; Yuichi Hatakeyama; Yoshihisa Koyama; Norio Inoue; Yuji Takebayashi; Kouji Sekikawa; Seiichi Takenoshita
The Japanese Journal of Gastroenterological Surgery | 2010
Izumi Nakamura; Yudai Nagasawa; Tetsuro Ito; Masaru Saito; Kensuke Kumamoto; Satoshi Suzuki; Yoshiyuki Endo; Shinji Ohki; Takashi Sugino; Seiichi Takenoshita
Gan to kagaku ryoho. Cancer & chemotherapy | 2011
Yu Sato; Shinji Ohki; Motoki Sassa; Kazunoshin Tachibana; Jin Ando; Yoshiyuki Endo; Satoshi Suzuki; Izumi Nakamura; Yoshihisa Koyama; Shinichi Suzuki; Seiichi Takenoshita
Gan to kagaku ryoho. Cancer & chemotherapy | 2006
Sekikawa K; Onogi H; Yazawa T; Yu Sato; Sakamoto W; Miyamoto K; Shotaro Fujita; Shinichi Suzuki; Yoshiyuki Endo; Shinji Ohki; Seiichi Takenoshita
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2001
Yoshiyuki Endo; Tsuneyuki Yoshida; Yoshiro Ando; Hitoshi Onogi; Izumi Nakamura; Shinji Ohki; Kenichi Takita; Atsuo Tsuchiya; Koji Sekikawa; Seiichi Takenoshita